Using biomarkers to predict response to combination therapies in BRAF-mutant melanoma

Grant McArthur, MBBS, BMedSci, PhD, FRACP, of the Peter MacCallum Cancer Centre, Melbourne, Australia, discusses the two currently approved combination therapies used for treating BRAF-mutant melanoma... Author: VJOncology Added: 09/27/2016
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts